Literature DB >> 29668369

Reply to E. Younger et al.

Thomas M Atkinson1, Mrinal M Gounder1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29668369      PMCID： PMC6362829          DOI： 10.1200/JCO.2018.78.0478

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

1.  Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

Authors:  Ethan Basch; Bryce B Reeve; Sandra A Mitchell; Steven B Clauser; Lori M Minasian; Amylou C Dueck; Tito R Mendoza; Jennifer Hay; Thomas M Atkinson; Amy P Abernethy; Deborah W Bruner; Charles S Cleeland; Jeff A Sloan; Ram Chilukuri; Paul Baumgartner; Andrea Denicoff; Diane St Germain; Ann M O'Mara; Alice Chen; Joseph Kelaghan; Antonia V Bennett; Laura Sit; Lauren Rogak; Allison Barz; Diane B Paul; Deborah Schrag
Journal:  J Natl Cancer Inst       Date:  2014-09-29       Impact factor: 13.506

2.  Health-Related Quality of Life in Patients With Sarcoma: Enhancing Personalized Medicine.

Authors:  Eugenie Younger; Roger Wilson; Winette T A van der Graaf; Olga Husson
Journal:  J Clin Oncol       Date:  2018-04-18       Impact factor: 44.544

Review 3.  Patient-Reported Physical Function Measures in Cancer Clinical Trials.

Authors:  Thomas M Atkinson; Angela M Stover; Daniel F Storfer; Rebecca M Saracino; Thomas A D'Agostino; Denise Pergolizzi; Konstantina Matsoukas; Yuelin Li; Ethan Basch
Journal:  Epidemiol Rev       Date:  2017-01-01       Impact factor: 6.222

4.  Patient-Reported Outcomes Labeling for Products Approved by the Office of Hematology and Oncology Products of the US Food and Drug Administration (2010-2014).

Authors:  Ari Gnanasakthy; Carla DeMuro; Marci Clark; Emily Haydysch; Esprit Ma; Vijayveer Bonthapally
Journal:  J Clin Oncol       Date:  2016-04-11       Impact factor: 44.544

Review 5.  The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review.

Authors:  Thomas M Atkinson; Sean J Ryan; Antonia V Bennett; Angela M Stover; Rebecca M Saracino; Lauren J Rogak; Sarah T Jewell; Konstantina Matsoukas; Yuelin Li; Ethan Basch
Journal:  Support Care Cancer       Date:  2016-06-03       Impact factor: 3.603

6.  Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.

Authors: 
Journal:  Health Qual Life Outcomes       Date:  2006-10-11       Impact factor: 3.186

7.  Population-based Aarhus Sarcoma Registry: validity, completeness of registration, and incidence of bone and soft tissue sarcomas in western Denmark.

Authors:  Katja Maretty-Nielsen; Ninna Aggerholm-Pedersen; Johnny Keller; Akmal Safwat; Steen Baerentzen; Alma B Pedersen
Journal:  Clin Epidemiol       Date:  2013-03-06       Impact factor: 4.790

8.  Patient-reported Symptoms of Tenosynovial Giant Cell Tumors.

Authors:  Heather L Gelhorn; Sandra Tong; Kelly McQuarrie; Christina Vernon; Jennifer Hanlon; Grant Maclaine; William Lenderking; Xin Ye; Rebecca M Speck; Richard D Lackman; Susan V Bukata; John H Healey; Vicki L Keedy; Stephen P Anthony; Andrew J Wagner; Daniel D Von Hoff; Arun S Singh; Carlos R Becerra; Henry H Hsu; Paul S Lin; William D Tap
Journal:  Clin Ther       Date:  2016-04-01       Impact factor: 3.393
  8 in total
  1 in total

1.  Prospective development of a patient-reported outcomes instrument for desmoid tumors or aggressive fibromatosis.

Authors:  Mrinal M Gounder; LeAnne Maddux; Jean Paty; Thomas M Atkinson
Journal:  Cancer       Date:  2019-11-06       Impact factor: 6.860
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.